Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections

被引:97
|
作者
Sprong, Tom
Roos, Dirk
Weemaes, Corry
Neeleman, Chris
Geesing, Christel L. M.
Mollnes, Tom Eirik
van Deuren, Marcel
机构
[1] Univ Nijmegen, Radboud Med Ctr, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Radboud Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Radboud Med Ctr, Dept Intens Care, NL-6500 HB Nijmegen, Netherlands
[4] Univ Nijmegen, Ctr Infect Dis, Nijmegen, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Netherlands Blood Transfus Serv, Cent Lab,Sanquin Res, NL-1105 AZ Amsterdam, Netherlands
[7] Bernhoven Hosp, Dept Pediat, Oss, Netherlands
[8] Univ Oslo Hosp, Rikshosp, Inst Immunol, Oslo, Norway
关键词
D O I
10.1182/blood-2005-07-2820
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The complement system is an essential element in our innate defense against infections with Neisseria meningitidis. We describe 2 cases of meningococcal septic shock, 1 of them fatal, in 2 children of a Turkish family. In the surviving patient, alternative pathway activation was absent and factor D plasma concentrations were undetectable. Concentrations of mannose-binding lectin (MBL), C1q, C4 and C3, factor B, properdin, factor H, and factor I were normal. Mutation analysis of the factor D gene revealed a T638 > G (Val213 > Gly) and a T640 > C (Cys214 > Arg) mutation in the genomic DNA from the patient, both in homozygous form. The consanguineous parents and an unaffected sister had these mutations in heterozygous form. In vitro incubation of factor-D-deficient plasma of the boy with serogroup B N meningitidis showed normal MBL-mediated complement activation but no formation of the alternative pathway C3-convertase C3bBbP, and severely decreased C3bc formation and terminal complement activation. The defect was restored after supplementation with factor D. In conclusion, this is the second report of a factor D gene mutation leading to factor D deficiency in a family with meningococcal disease. This deficiency abolishes alternative-pathway dependent complement activation by N meningitidis, and leads to an increased susceptibility to invasive meningococcal disease.
引用
收藏
页码:4865 / 4870
页数:6
相关论文
共 50 条
  • [21] Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D
    GonzalezRubio, C
    GonzalezMuniz, R
    JimenezClavero, MA
    Fontan, G
    LopezTrascasa, M
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1996, 1295 (02): : 174 - 178
  • [22] The Factor H protein family: The switchers of the complement alternative pathway
    Lucientes-Continente, Laura
    Marquez-Tirado, Barbara
    Goicoechea de Jorge, Elena
    IMMUNOLOGICAL REVIEWS, 2023, 313 (01) : 25 - 45
  • [23] ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY ANTISERUM TO FACTOR-B
    WILSON, MR
    ARROYAVE, CM
    TAN, EM
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1979, 93 (03): : 493 - 498
  • [24] PLASMA FACTOR TRIGGERING ALTERNATIVE COMPLEMENT PATHWAY ACTIVATION BY LIPOSOMES
    FUNATO, K
    YAMASHITA, C
    KAMADA, J
    TOMINAGA, S
    KIWADA, H
    PHARMACEUTICAL RESEARCH, 1994, 11 (03) : 372 - 376
  • [25] Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway
    Hayashi, Manabu
    Machida, Takeshi
    Ishida, Yumi
    Ogata, Yusuke
    Omori, Tomoko
    Takasumi, Mika
    Endo, Yuichi
    Suzuki, Toshiyuki
    Sekimata, Masayuki
    Homma, Yoshimi
    Ikawa, Masahito
    Ohira, Hiromasa
    Fujita, Teizo
    Sekine, Hideharu
    JOURNAL OF IMMUNOLOGY, 2019, 203 (06): : 1411 - 1416
  • [26] Small-molecule factor D inhibitors targeting the alternative complement pathway
    Jürgen Maibaum
    Sha-Mei Liao
    Anna Vulpetti
    Nils Ostermann
    Stefan Randl
    Simon Rüdisser
    Edwige Lorthiois
    Paul Erbel
    Bernd Kinzel
    Fabrice A Kolb
    Samuel Barbieri
    Julia Wagner
    Corinne Durand
    Kamal Fettis
    Solene Dussauge
    Nicola Hughes
    Omar Delgado
    Ulrich Hommel
    Ty Gould
    Aengus Mac Sweeney
    Bernd Gerhartz
    Frederic Cumin
    Stefanie Flohr
    Anna Schubart
    Bruce Jaffee
    Richard Harrison
    Antonio Maria Risitano
    Jörg Eder
    Karen Anderson
    Nature Chemical Biology, 2016, 12 : 1105 - 1110
  • [27] Small-molecule factor D inhibitors targeting the alternative complement pathway
    Maibaum, Jurgen
    Liao, Sha-Mei
    Vulpetti, Anna
    Ostermann, Nils
    Randl, Stefan
    Rudisser, Simon
    Lorthiois, Edwige
    Erbel, Paul
    Kinzel, Bernd
    Kolb, Fabrice A.
    Barbieri, Samuel
    Wagner, Julia
    Durand, Corinne
    Fettis, Kamal
    Dussauge, Solene
    Hughes, Nicola
    Delgado, Omar
    Hommel, Ulrich
    Gould, Ty
    Mac Sweeney, Aengus
    Gerhartz, Bernd
    Cumin, Frederic
    Flohr, Stefanie
    Schubart, Anna
    Jaffee, Bruce
    Harrison, Richard
    Risitano, Antonio Maria
    Eder, Jorg
    Anderson, Karen
    NATURE CHEMICAL BIOLOGY, 2016, 12 (12) : 1105 - +
  • [28] Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
    Yu, Jia
    Yuan, Xuan
    Chen, Hang
    Chaturvedi, Shruti
    Braunstein, Evan M.
    Brodsky, Robert A.
    BLOOD, 2020, 136 (18) : 2080 - 2089
  • [29] Complement factor D, a novel serine protease
    Volanakis, JE
    Narayana, SVL
    PROTEIN SCIENCE, 1996, 5 (04) : 553 - 564
  • [30] Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease
    Kuijpers, Taco W.
    Nguyen, Melanie
    Hopman, Carla Th. P.
    Nieuwenhuys, Ed
    Dewald, Georg
    Lankester, Arjan C.
    Roos, Anja
    van der Ende, Arie
    Fijen, Cees
    de Boer, Martin
    MOLECULAR IMMUNOLOGY, 2010, 47 (04) : 671 - 677